C3b/C4b Complement Receptor-like molecules and uses thereof

Details C3b/C4b Complement Receptor-like molecules and uses thereof C3b/C4b Complement Receptor-like molecules and uses thereof

2006-05-09

2006-05-09

Andres, Janet L. (Department: 1649)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C514S002600, C514S012200, C530S402000

Reexamination Certificate

active

07041796

ABSTRACT:
Novel C3b/C4b CR-like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing C3b/C4b CR-like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with C3b/C4b CR-like polypeptides.

REFERENCES:
patent: 5691147 (1997-11-01), Draetta et al.
patent: 198 18 620 (1999-10-01), None
patent: 1 074 617 (2001-02-01), None
patent: 1 130 094 (2001-09-01), None
patent: WO 00/71710 (2000-11-01), None
Genbank Accession No. AL079279, “Homo sapiensmRNA Full Length Insert cDNA Clone EUROIMAGE 248114,” Bassi, et al., 1999.
Gilges, et al., “Polydom: A Secreted Protein with Pentraxin, Complement Control Protein, Epidermal Growth Factor and von Willebrand Factor A Domains,”Biochemical Journal352:49-59 (2000).
International Search Report, PCT/US01/23548, European Patent Office Searching Authority.

Affiliated with

Also associated with

Rating

C3b/C4b Complement Receptor-like molecules and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C3b/C4b Complement Receptor-like molecules and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C3b/C4b Complement Receptor-like molecules and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3524922